CGEMCullinan Therapeutics, Inc.

$894M

FY 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$191M

Net Income

-$153M

EPS (Diluted)

$-3.69

Cash Flow

Operating Cash Flow

-$134M

Free Cash Flow

-$134M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$484M

Total Liabilities

$30M

Stockholders' Equity

$454M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$191M	$145M	-232.1%
Net Income	-$153M	$111M	-237.7%

CGEM FY 2023 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena